The available evidence appears to suggest that in tumours in which FGFR2 is activated, such as breast, lung, and pancreas, KGF action may protect against the cytotoxic effects of radiation or chemotherapy by inhibiting the induction of apoptosis [102], [61, 71, 103–107]. The gene discussed is FGF7; the disease is neoplasm.